ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

UEPS Net 1 Ueps Technologies Inc

4.58
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Net 1 Ueps Technologies Inc NASDAQ:UEPS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.58 3.85 6.50 0 01:00:00

Free Research Reports on GMCR, UEPS, PPHM and TOL Issued by the Bedford Report

05/12/2012 1:45pm

Marketwired


Net 1 Ueps Technologies (NASDAQ:UEPS)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Net 1 Ueps Technologies Charts.

The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Green Mountain Coffee Roasters Inc. (NASDAQ: GMCR) shares have been on an impressive run gaining nearly 50 percent in the past week. Analysts at Lazard Capital have recently raised the company's price target to $56.00.

Find out more about Green Mountain Coffee Roasters including full access to the free equity report at: www.BedfordReport.com/GMCR

Net 1 UEPS Technologies Inc. (NASDAQ: UEPS) shares plummeted 59 percent on nearly 12 million shares traded Tuesday after it was reported that the company is being investigated by the U.S. Department of Justice and the Federal Bureau of Investigation over payments made to South African government officials.

Find out more about Net 1 UEPS Technologies including full access to the free equity report at: www.BedfordReport.com/UEPS

Peregrine Pharmaceuticals (NASDAQ: PPHM) is focused on developing monoclonal antibodies for the treatment and diagnosis of cancer. The company is scheduled to release their fiscal year 2013 second quarter results after market close on Dec. 10, 2012.

Find out more about Peregrine Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/PPHM

Toll Brothers Inc. (NYSE: TOL) shares spiked in early Tuesday trading after reporting fourth quarter net income soared to $411.4 million, which was largely due to an income tax benefit of $350.7 million.

Find out more about Toll Brothers including full access to the free equity report at: www.BedfordReport.com/TOL

Disclaimer: Equity News Circuit is not a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security. A third party, bedfordreport.com has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release.

Contact Information: Equity News Circuit Email Contact

1 Year Net 1 Ueps Technologies Chart

1 Year Net 1 Ueps Technologies Chart

1 Month Net 1 Ueps Technologies Chart

1 Month Net 1 Ueps Technologies Chart